S.4348: Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022
Sponsored by: Sen. Patty Murray
Committee On Health, Education, Labor, And Pensions. Reported By Senator Murray With An Amendment In The Nature Of A Substitute. Without Written Report. on 07/13/2022
You have voted S.4348: Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022 Biosimilar User Fee Amendments of 2022 Food and Drug Administration Safety and Landmark Advancements Act of 2022 Modernization of Cosmetics Regulation Act of 2022 Verifying Accurate Leading-edge IVCT Development Act of 2022 Generic Drug User Fee Amendments of 2022 VALID Act of 2022.
Pharmacy Benefit Manager Transparency Act of 2022 [S.4293]
[Consumer Protection ]
[Healthcare ]
[Pharmaceuticals ]
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
S.4293: Pharmacy Benefit Manager Transparency Act of 2022
Sponsored by: Sen. Chuck Grassley
Committee On Commerce, Science, And Transportation. Reported By Senator Cantwell With An Amendment In The Nature Of A Substitute. Without Written Report. on 12/14/2022
Restaurant Relief Act [S.4282]
[Small Business ]
[Economic Development ]
[Funding ]
[Grants ]
[Public Health ]
[Healthcare ]
[Labor, Jobs, Employment ]
A bill to provide COVID relief for restaurants, and for other purposes.
S.4282: Restaurant Relief Act
Sponsored by: Sen. Rob Portman
Read Twice And Referred To The Committee On Small Business And Entrepreneurship. on 05/19/2022
HB-7667: Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022
Sponsored by: Rep. Cathy McMorris Rodgers
Received In The Senate. on 06/09/2022
You have voted HB-7667: Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022.
Women’s Health Protection Act of 2022 [S.4132]
[Healthcare ]
[Reproductive Rights / Abortion ]
[Public Health ]
A bill to protect a person's ability to determine whether to continue or end a pregnancy, and to protect a health care provider's ability to provide abortion services.
S.4132: Women’s Health Protection Act of 2022
Sponsored by: Sen. Richard Blumenthal
Cloture On The Motion To Proceed To The Measure Not Invoked In Senate By Yea-nay Vote. 49 - 51. Record Vote Number: 170. on 05/11/2022
Telehealth Extension and Evaluation Act [HB-7573]
[Healthcare ]
[Medicare and Medicaid ]
[Technology and Innovation ]
[Telecommunications ]
[Public Health ]
[Senior Citizens ]
To amend titles XI and XVIII of the Social Security Act to extend certain telehealth services covered by Medicare and to evaluate the impact of telehealth services on Medicare beneficiaries, and for other purposes.
HB-7573: Telehealth Extension and Evaluation Act
Sponsored by: Rep. Don Bacon
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 11/01/2022
American Made Medicine Act [HB-7410]
[Healthcare ]
[Manufacturing ]
[Taxes ]
[Pharmaceuticals ]
[Economic Development ]
To amend the Internal Revenue Code of 1986 to provide for credits against tax for domestic medical and drug manufacturing and advanced medical manufacturing equipment.
HB-7410: American Made Medicine Act
Sponsored by: Rep. Darin LaHood
Introduced In House on 04/05/2022
American Made Pharmaceuticals Act of 2022 [HB-7400]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Manufacturing ]
[Trade ]
[Budget and Spending ]
[Public Health ]
To direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
HB-7400: American Made Pharmaceuticals Act of 2022
Sponsored by: Sen. Markwayne Mullin
Referred To The Subcommittee On Health. on 04/06/2022
American Made Pharmaceuticals Act of 2022 [S.3991]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Manufacturing ]
A bill to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
S.3991: American Made Pharmaceuticals Act of 2022
Sponsored by: Sen. Tom Cotton
Read Twice And Referred To The Committee On Finance. on 04/05/2022
Protecting our Pharmaceutical Supply Chain from China Act of 2022 [HB-7121]
[Pharmaceuticals ]
[Healthcare ]
[Trade ]
[National Security ]
[Funding ]
[Public Health ]
To require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in the People's Republic of China, and for other purposes.
HB-7121: Protecting our Pharmaceutical Supply Chain from China Act of 2022
Sponsored by: Rep. Brian Babin
Referred To The Subcommittee On Health. on 03/18/2022
Relief for Families Act of 2022 [S.3842]
[Budget and Spending ]
[Funding ]
[Human Services ]
[Social Security ]
[Family-Related Legislation ]
[Inflation ]
A bill to amend title VI of the Social Security Act to permit State and local coronavirus fiscal recovery funds to be used to address increased costs of essential items.
S.3842: Relief for Families Act of 2022
Sponsored by: Sen. Raphael Warnock
Committee On Banking, Housing, And Urban Affairs. Hearings Held. on 03/22/2022
S.3799: PREVENT Pandemics Act Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act
Sponsored by: Sen. Patty Murray
Committee On Health, Education, Labor, And Pensions. Ordered To Be Reported With An Amendment In The Nature Of A Substitute Favorably. on 03/15/2022
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 [HB-6833]
[Healthcare ]
[Pharmaceuticals ]
[Budget and Spending ]
To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes.
HB-6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Sponsored by: Rep. Gerald Connolly
Became Public Law No: 117-180. on 09/30/2022
Affordable Insulin Now Act [S.3700]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Insurance ]
A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans.
S.3700: Affordable Insulin Now Act
Sponsored by: Sen. Robert Casey
Read Twice And Referred To The Committee On Finance. on 02/17/2022
Opioid Treatment Access Act of 2022 [S.3629]
[Healthcare ]
[Public Health ]
[Overdose Prevention ]
[Pharmaceuticals ]
A bill to authorize a study on certain exemptions for treatment of opioid use disorder through opioid treatment programs during the COVID-19 public health emergency, and for other purposes.
S.3629: Opioid Treatment Access Act of 2022
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 02/10/2022
Telehealth Extension and Evaluation Act [S.3593]
[Healthcare ]
[Medicare and Medicaid ]
[Technology and Innovation ]
[Telecommunications ]
[Public Health ]
[Senior Citizens ]
A bill to amend titles XI and XVIII of the Social Security Act to extend certain telehealth services covered by Medicare and to evaluate the impact of telehealth services on Medicare beneficiaries, and for other purposes.
S.3593: Telehealth Extension and Evaluation Act
Sponsored by: Sen. Angus King
Read Twice And Referred To The Committee On Finance. on 02/08/2022
Relating To Prescription Drugs. [SB-322]
[Healthcare ]
[Insurance ]
[Pharmaceuticals ]
[Consumer Protection ]
Requires that if a proposed increase in the wholesale price of certain drugs would result in a 16 per cent or more price increase over a two-year period, the drug manufacturer shall notify various drug insurance providers.
SB-322: Relating To Prescription Drugs.
Sponsored by: Sen. Jarrett Keohokalole
Carried Over To 2022 Regular Session. on 12/10/2021